Progress of Treatment and Changing Views on the Role of Compensatory Mechanisms in Chronic Heart Failure

  • Masahiko Iizuka
Conference paper


In this brief review the progress in the treatment of chronic heart failure is discussed from standpoint of understanding of mechanisms of heart failure.Nobody would disagree that an effective treatment must be based on thorough understanding of disease mechanisms. In reality,however,it is not the case in heart failure.We are treating heart failure without knowing its exact mechanisms.In this area,con¬versely,development of treatment has stimulated and accelerated stud¬ies on the mechanisms of disease.So in this article how each drug was introduced and how progress in understanding of mechanisms follo- ed will be presented.


Chronic Heart Failure Heart Failure Patient Atrial Natriuretic Peptide Inotropic Agent Atrial Natriuretic Peptide Level 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ferguson DW,Berg JW,Sanders JS, Roach PJ,Kempf JS,Kienzle MG (1989) Sympathoinhibitory responses to digitalis glycosides in heart failure patients. Circulation 80: 65–77PubMedCrossRefGoogle Scholar
  2. 2.
    Guyton AC,Jones CE,Coleman TG (1973) Circulatory physiology 2nd ed.W.B.Saunders,PhiladelphiaGoogle Scholar
  3. 3.
    Ikenouchi H,Iizuka M,Sato H,Momomura S,Serizawa T,Sugimoto T (1991) Forearm venous distensibility in relation to severity of symptoms and hemodynamic data in patients with congestive heart failure. Jpn Heart J: 17–34Google Scholar
  4. 4.
    Sunagawa K,Maughan WL,Sagawa K (1985) Optimal arterial resistance for the maximal stroke work studied in isolated canine left ventricle. Circ Res 56:586–595PubMedGoogle Scholar
  5. 5.
    Packer M (1990) Role of sympathetic nervous system in chronic heart failure. Circulation 82:suppl I 1–6CrossRefGoogle Scholar
  6. 6.
    Katz AM (1978) A new inotropic drug:its promise and a caution. N Engl J Med 299: 1409–1410PubMedCrossRefGoogle Scholar
  7. 7.
    LeJemtel TH,Sonnenblick EH (1984) Should the failing heart be stimulated? N Engl J Med 310:1384–1385PubMedCrossRefGoogle Scholar
  8. 8.
    Morgan JP (1990) Mechanisms of action of inotropic drugs. Update to Heart Disease ed Braunwald E, 136–144Google Scholar

Copyright information

© Springer-Verlag Tokyo 1992

Authors and Affiliations

  • Masahiko Iizuka
    • 1
  1. 1.1st Department of Internal MedicineDokkyo University School of MedicineTochigiJapan

Personalised recommendations